RenovoRx RNXT
NASDAQ RNXT
$1.32 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

RenovoRx (RNXT) FCF Margin Growth (1y) (2026)

RenovoRx (RNXT) FCF Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -89.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -1,183.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 26,102.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 869.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 769.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 19,111.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - 811.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 4,109.00
10 RenovoRx 61.96 Mn 61.96 Mn 766,000.00 20,809.00

Historic Data

Download Data
DateValue
Jun 30, 2026 21,535.00
Mar 31, 2026 105,745.00